Analyst Ratings for Surface Oncology (SURF)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/20/2023 | H.C. Wainwright | Swayampakula Ramakanth | Downgrade | Neutral (Buy) |
5.00 (N/A) |
0.79 (1.07) |
35.44% | Details |
| 6/20/2023 | Baird | Colleen Kusy | Downgrade | Neutral (Outperform) |
1.00 (6.00) |
0.74 (1.07) |
44.59% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


